News from the EASLCongress 2023 meeting in Vienna
From the "late-breaking" abstract session on June 24, 2023, results of the pre-planned futility analysis of the Phase3 PRIMIS study (cilofexor in PSC) were presented.
PRIMIS (Phase 3 Study of Cilofexor) News from EASL Congress 2023